Barron's : Lucerne Capital Fund Bets on Europe

Lucerne Capital Fund Bets on Europe
Hedge fund managers Pieter Taselaar and Thijs Hovers see opportunities among European mid-cap stocks.

February Hedge Funds: Best, Worst, Biggest

Pieter Taselaar is well traveled. He was studying at Columbia business school when he learned that his father, back in Rotterdam in the Netherlands, had sold the family shipping-supply business he was being trained to run. So, after graduation, Taselaar wound up in Amsterdam instead, working for investment bank ABN, where he advised European companies on mergers and acquisitions. In 1996, the firm, now ABN Amro, shipped him back to New York to help expand its stock brokerage. His experience in valuing small and midsize takeover targets had given him a healthy skepticism for equity analysis. “People don’t do a lot of in-depth work, particularly in Europe,” he says.

His life—and his locale—changed once more, when Taselaar decided it was time to start his own firm. In 2002, appropriately enough, he named his long-short equity hedge fund Lucerne Capital Fund after the Swiss hometown of his initial investor. He based it in Greenwich, Conn., but chose to focus across the Atlantic on European stocks.

TODAY LUCERNE OVERSEES $478 MILLION in assets. In 2007 Taselaar, now 52, hired fellow Dutchman and former colleague Thijs Hovers, who had run ABN Amro’s European mid-cap equity research team and had accompanied him on a number of trans-Atlantic trips to visit European companies. Hovers, 40, later became a partner in Lucerne.


Hovers (left) and Taselaar, of top-performing Lucerne fund, see two more years of stock gains in Europe. Photo: Matthew Furman for Barron’s
The two spend a lot of their time researching balance sheets of mid-cap companies, many of which they believe suffer from poor coverage from European analysts. They like companies with strong free cash flow that might look risky, but actually command a dominant market share and strong pricing power. Lucerne won’t buy a stock unless the partners think that 30% upside is possible within a year, including dividends, based on discounted cash flow calculations.

This straightforward strategy has produced some of the best returns of any long-short equity hedge fund in the past 13 years. Since inception in 2002, the fund is up 14.8% annualized, net of fees, through Feb. 28. It has trounced its benchmark, the Stoxx Europe 600 Index, up a meager 2.1% a year during the same period. It’s also been on a roll for the three years ended Feb. 28, aided by unexpected European gains last year, delivering a 20.2% net return. Management fee: 1.5%. Performance fee: 20%. Minimum investment is $250,000.

Taselaar and Hovers don’t impose gates on withdrawals. While that’s great for investors, it didn’t help in 2008, explains Mark Anson, chief investment officer of Acadia Investment Management, the family office of Robert Bass, which invests in Lucerne. In a year when the Standard & Poor's 500 index fell 37%, investors who needed cash “used us as their ATM machine,” Taselaar recalls, forcing the fund to sell stocks it liked. Between redemptions and falling markets, Lucerne lost 43% of its assets, about 10% to 15% worse than if they had been able to hold onto stocks. Lucerne rebounded with an 87% gain in 2009.

TASELAAR AND HOVERS expect another strong year in 2015, driven by unlocked value in mid-cap stocks. Lucerne has stocked its portfolio with mid-cap companies they believe will grow faster than others on the Continent.

Some of Lucerne’s 25 long positions play the weakening euro, which has fallen by more than 20% since last May—and, Taselaar forecasts, will slip another 10% by year end. That will make European exports, particularly German cars, more competitive, he says.

Lucerne Capital Selected Holdings
Company/Ticker Industry
Braas Monier Building Group /BMSA.Germany Construction materials
Hella KGaA Hueck /HLE.Germany Car parts
Mediobanca /MB.Italy Finance
Stabilus/ STM.Germany Car parts
Tele Columbus/TC1.Germany Cable TV
Eurazeo/RF.France Private Equity
Ei Towers/EIT.Italy Cable TV towers

Note: All returns as of Feb. 28. Three-year, five-year and since-inception returns are annualized. Source: Lucerne Capital Management
Lucerne doesn’t buy large-cap car makers, but it has bought shares in German auto-parts makers such as Hella KGaA Hueck (ticker: HLE.Germany), which makes LED lighting systems. With only a couple of real competitors, Hella fits Lucerne’s pursuit of dominant market share and pricing power. It also has a free cash flow yield of about 8%. Hella is keeping pace with an annual growth rate of 20% to 25% for the automotive LED lighting industry worldwide. Taselaar and Hovers set a target price of 58 euros ($63.22) for the stock, up from its recent level of €46.

With the European Central Bank and the region’s other central banks driving interest rates down, Taselaar and Hovers expect companies and consumers to borrow and spend more. As a result, they project rising demand for new construction.

That’s why they bought shares of Braas Monier Building Group (BMSA.Germany), a German roof-tile maker. Braas also has a strong market position and has been able to withstand the pressures created by a 30-year low in European construction. The company remains profitable; its strong cash flow is equivalent to 10% of its market value, and it has a 10% free cash flow yield. The stock has 50% upside by Lucerne’s calculations.

Lower rates also mean cheaper credit for European companies to finance acquisitions. One acquirer Lucerne likes is EI Towers (EIT.Italy), which operates transmission towers for both media and mobile telephony in Italy. EI Towers has already bid €1.2 billion for a majority stake in its domestic rival RAI Way, roughly doubling EI Towers’ size. “EI Towers is in a good position to acquire,” says Hovers, because it has very little debt and a free cash flow yield of 7%.

He believes the shares can hit €80.

Lucerne is currently short about 15 companies that have major cash-flow problems, according to Taselaar.

One is Royal Imtech (IM.Netherlands), a Dutch contractor that installs electrical wiring in large public buildings. They shorted the stock, when it was trading at €9.83, and since then it has fallen to a split-adjusted €4.85. But Taselaar says he doesn’t plan to cover until the “equity value reaches zero.” To pay its creditors, Imtech has held two rights offerings, but still has about €450 million in debt, uncomfortably close to its €550 million market value.

Taselaar and Hovers still see loads of opportunities. “It will take a while for people to believe that Europe is a better market,” says Taselaar. “You could be looking at a two-year time frame.”

And lots more frequent-flier miles.

(BFW) LO, RAI May Consult With FTC Ahead of Merger Decision: WSJ


LO, RAI May Consult With FTC Ahead of Merger Decision: WSJ
2015-03-29 18:19:13.225 GMT


By Joe Sabo
(Bloomberg) -- Lorillard/Reynolds American meeting with
members of FTC expected this wk, WSJ says, citing people
familiar w/ matter.
* Final vote by commission could come as soon as this wk,
unidentified people familiar w/ review say
* NOTE: FTC Staff Expects to Make Recommendation on LO/RAI
Soon: DJ


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Joe Sabo in Princeton at +1-609-279-3119 or
jsabo@bloomberg.net
To contact the editor responsible for this story:
Andrea Snyder at +1-202-624-1831 or
asnyder5@bloomberg.net

>>> Barrons Summary

Barron's Weekend Summary: Positive on JPM, HDS, SJM 

Cover story: Positive on JPM: Chief Jamie Dimon "has cemented his position as the world's top banker," using the firm's strength to gain ground in investment banking, credit cards, and asset management; Shares could rise 30% in a year, not including a 2.9% yield.

Features: 1) Positive on HDS: Company, one of the country's largest wholesalers of commercial building supplies, is affected by economic cycles, but has trimmed underperforming business lines and paid down debt, and has an upside of 30% or more; 2) Investors still hold about $50B of auction-rate securities that could remain outstanding for another 10 to 20 years, some yielding 0.5% or less; 3) Positive on SJM: Maker of jams and jellies has gotten into the pet food business with its purchase of Big Heart Pet Brands, a deal that could help it achieve double-digit earnings growth. 

Tech Trader: Positive on SWKS, BRCM, LRCX, TXN, ATML: Semiconductors are priced in dollars, so chipmaker shares have dropped on signs the strong greenback may be crimping demand, but though there may be more pain ahead, there is nothing fundamentally wrong with the industry.

Trader: "Stocks could be in a dead zone for the next week--or two or three--as the economic-data schedule is relatively light and there is no news scheduled from the Fed; Cautious on SHAK: Shares of fast-casual chain appear overvalued, as New York-centric company may not be able to generate strong profits as it expands elsewhere; Cautious on CPB: Company, long seen as a takeover target, could see shares drop if that possibility becomes less likely following the Heinz-KRFT deal. 

Follow-Up: Positive on HAS: Toy maker is doing many things well with its seven key brands; shares could rise further if movie tie-up deals with DIS pay off, so investors should keep shares in play for now; Cautious on URBN: Despite strides, retailer still faces problems, now may be the time for investors to take profits or wait for a pullback to buy in.

Profile: Pieter Taselaar and Thijs Hovers, portfolio managers, Lucerne Capital, see good opportunities in Europe (selected holdings: Braas Monier Building Group, Hella KGaA Hueck, Mediobanca, Stabilus, Tele Columbus, Eurazeo, EiTowers).

Interview: Mark Roberts, founder, Off Wall Street Consulting Group (picks: CCK; pans: TRAK, SLH, HCSG).

European Trader: Positive on ING Groep: "Dutch bank has bounced back from its near collapse during the financial crisis to become a solid performer among European financial companies.; 

Asian Trader: India's bull market could be slowing down, becoming a stockpicker's market, with TTM and Bharti Airtel good defensive plays. 

Emerging Markets: Despite the negative view of Iran in the U.S., some analysts see the country as the next great emerging market, and a nuclear deal is likely to throw open its markets. 

Commodities: Wheat prices are on the rise amid bad crops in Russia and Ukraine and a strong dollar, and could more than double from current levels, depending on the weather. 

Streetwise: Companies that have been big buyers of their own shares, such as ANTM, HAL, ITW, CBS, KR, and LYB have typically underperformed the S&P 500 during the blackout period before earnings season.

>>> PBoC Gov Zhou: China needs to be vigilant for signs of deflation; May update

PBoC Gov Zhou: China needs to be vigilant for signs of deflation; May update laws on currency controls; Sees room for more rate cuts - financial press 
- Policymakers are monitoring global economy and decline in commodity prices.
- Monetary policy is normalizing to a "new normal."
- Says: "Inflation in China is also declining. We need to have vigilance if this can go further to reach some sort of deflation or not... This year, we may be able to thoroughly update the laws on foreign exchange controls... If we can set up new rules, we will have basically established free capital account convertibility... China still has room to adjust both price [interest rate] and quantitative... We can employ comprehensive policy measures to adjust the economy."

(NS8) Globes (IL): Teva close to major acquisition - report


Globes (IL): Teva close to major acquisition - report
2015-03-29 19:32:11.399 GMT


Globes, Tel Aviv, Israel
March 29--Wall Street analysts believe that Teva
Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is very
close to making a major acquisition that may be announced by
September, according to a report by "Bloomberg" on Teva.
The report was published in the US, following hints
dropped by Teva executives in recent weeks, among them CEO Erez
Vigodman, that Teva was considering acquisitions. The Teva
share is only 4.8% below its all-time high on Wall Street.
Vigodman said last month that Teva was ready to switch to
a strategy of inorganic growth, following a long period in
which it had concentrated on defending its Copaxone patent and
substantial cost cutting measures designed to position the
company for the day after Copaxone. His statement was warmly
received by investors, who pushed the share up to its highest
level in the past five years.
"The closer we get to September, the closer they're going
to get to the finish line on completing a deal or at least
announcing a deal," CRT Capital Group analyst Timothy Chiang
told Bloomberg. "That's what the markets are hoping for, and
what I'm hoping for."
Teva has already managed to transfer 60% of its Copaxone
patients to its new version of the drug, administered by
injection three times a week, instead of the old version, which
is administered daily. The Teva share has surged 8.7% this
month.
"Our strong focus during 2014 was on getting our house in
order first, solidifying the foundation, developing the
cylinder that will fire for us in years to come," Vigodman said
in a February 5 conference call with investors. "We are
reorienting the direction during 2015 towards inorganic moves
as well."
JP Morgan says that Teva has over $10 billion in debt
capacity to spend on acquisitions and could go after Mylan
Inc., which agreed to buy Abbott Laboratories' generic drug
unit last year. Wells Fargo, on the other hand, believes that
this is unlikely.

>>> DMG Mori Seiki expects to gain over 50% stake in DMG Mori Seiki AG

DMG Mori Seiki expects to gain over 50% stake in DMG Mori Seiki AG 

DMG Mori Seiki Co., Ltd. [TYO:6141] expects to gain more than 50% stake in DMG Mori Seiki AG [ETR:GIL] in its ongoing takeover bid, the Nihon Keizai Shimbun reported.

DMG Mori Seiki President Masahiko Mori said in an interview in Tokyo with the Japanese language newspaper that it is likely that the company will gain at least a 50% stake in the German machinery maker, according to the report.

Nihon Keizai Shimbun

>>> Fosun International Group in talks to buy Phoenix Holdings majority stake, c

Fosun International Group in talks to buy Phoenix Holdings majority stake, considers buying five insurance firms overseas 

Fosun International [HKG: 656] plans to buy a majority stake in Israeli insurance company Phoenix Holdings for nearly USD 500m and talks over the deal are expected to finish in June, Chinese-language Sina.com reported, citing an unnamed source.

Fosun International, the Hong Kong-listed Chinese conglomerate, plans to intensify its efforts on overseas acquisitions, and it is in talks to acquire five insurance firms in the U.S., Europe and Asia this year with a budget of USD 2.4bn, according to the report.

Liang Xinjun, the CEO of Fosun International, said in an interview with the Wall Street Journal that the company is in exclusive talks with five different insurance companies and has completed due diligence on these targets. Liang refused to disclose the names of these targets, the Sina.com report said.

Sina.com

>>> Standard Chartered management changes could open door to merger with ANZ

Standard Chartered management changes could open door to merger with ANZ
Upcoming management changes at Standard Chartered (StanChart), the UK-based lender, could open the door to a potential merger with Australia and New Zealand Banking Group (ANZ), the ASX-listed bank, the Australian Financial Review reported.

The report cited ANZ’s chief executive, Mike Smith, as saying that the possibility of a deal has taken a major step forward following news that StanChart’s current chairman, chief executive, and three directors are set to exit.

Smith said that StanChart’s previous management was not excited about deal with ANZ. Smith said that ANZ would take a wait and see approach, when asked whether the management changes at StanChart would open the door to a merger.

Smith noted that any deal would likely face substantial regulatory obstacles.

The article went on to note that Temasek, which owns 18% of StanChart, is believed to have been approached by two of China’s large banks, Bank of China and Industrial Commercial Bank of China, in the past with interest in its holding.
Australian Financial Review

(BFW) Slater & Gordon Close to GBP700m Quindell Takeover: FT


Slater & Gordon Close to GBP700m Quindell Takeover: FT
2015-03-29 18:04:50.190 GMT


By Robin Stringer
(Bloomberg) -- Law firm close to acquiring services unit of
insurance claims processor for around GBP700m, FT reports,
citing people familiar.
* Quindell expected to return GBP500m proceeds from sale to
holders, one of people familiar told FT
* Buy announcement could come as early as Sunday
* Quindell, Slater & Gordon did not comment to FT
* NOTE: March 16, Quindell Confirms Talks W/Slater & Gordon on
PSD Sale; Shrs Rise

For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Robin Stringer in New York at +1-212-617-2526 or
rstringer7@bloomberg.net
To contact the editors responsible for this story:
Andrea Snyder at +1-202-624-1831 or
asnyder5@bloomberg.net
Robin Stringer

(FTI) Bid for Rexam sparks fears over loss of UK expertise


Bid for Rexam sparks fears over loss of UK expertise
2015-03-29 10:43:05.532 GMT


Tanya Powley, Manufacturing Correspondent
March 29 (Financial Times) -- From glow-in-the-dark
versions to market alcopops in Russian nightclubs to a
one-litre beer container popular in Germany, the humble can h...

The full story is available on Bloomberg to Financial Times
corporate subscribers. <a href="entreq:43358">Click here</a> to receive details on pricing.